147 related articles for article (PubMed ID: 36326836)
1. Clinical characteristics and treatment outcomes of secondary ocular adnexal lymphoma.
Yang Y; Jin X; Wang Y; Ma R; He W
Clin Exp Ophthalmol; 2023 Mar; 51(2):154-161. PubMed ID: 36326836
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
[TBL] [Abstract][Full Text] [Related]
3. Ocular adnexal lymphomas: An eye care service experience in Turkey.
Kiziltas B; Baskan C; Duman R; Dal MS
Niger J Clin Pract; 2018 Jun; 21(6):711-715. PubMed ID: 29888716
[TBL] [Abstract][Full Text] [Related]
4. Ocular adnexal follicular lymphoma: a multicenter international study.
Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and treatment outcomes of diffuse large B-cell lymphoma involving the eye and ocular adnexa in East Asia.
Han SH; Kim YD; Jang J; Park JW; Young SM; Woo KI
Acta Ophthalmol; 2021 Nov; 99(7):773-782. PubMed ID: 33421300
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma.
Sagiv O; Thakar SD; Manning JT; Kandl TJ; Fayad LE; Fowler N; Hagemeister FB; Fanale MA; Pinnix CC; Samaniego F; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2019; 35(3):243-246. PubMed ID: 30124609
[TBL] [Abstract][Full Text] [Related]
7. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
White WL; Ferry JA; Harris NL; Grove AS
Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
[TBL] [Abstract][Full Text] [Related]
8. Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma.
Thuro BA; Ning J; Peng SA; Pace ST; Dudeja G; Ozgur O; Turturro F; Samaniego F; Hagemeister FB; Fayad LE; Fowler NH; Pinnix CC; Debnam JM; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2017; 33(5):355-360. PubMed ID: 27636243
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification.
Kwon M; Lee JS; Lee C; Yoon DH; Sa HS
Br J Ophthalmol; 2021 Feb; 105(2):279-284. PubMed ID: 32327417
[TBL] [Abstract][Full Text] [Related]
10. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
11. Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions.
Yoon JS; Ma KT; Kim SJ; Kook K; Lee SY
Ophthalmic Plast Reconstr Surg; 2007; 23(2):94-9. PubMed ID: 17413620
[TBL] [Abstract][Full Text] [Related]
12. Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.
Aronow ME; Portell CA; Rybicki LA; Sweetenham JW; Singh AD
Ophthalmology; 2013 Sep; 120(9):1915-9. PubMed ID: 23664470
[TBL] [Abstract][Full Text] [Related]
13. Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.
Tuncer S; Tanyıldız B; Basaran M; Buyukbabani N; Dogan O
Curr Eye Res; 2015; 40(8):780-5. PubMed ID: 25247376
[TBL] [Abstract][Full Text] [Related]
14. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci.
Rosado MF; Byrne GE; Ding F; Fields KA; Ruiz P; Dubovy SR; Walker GR; Markoe A; Lossos IS
Blood; 2006 Jan; 107(2):467-72. PubMed ID: 16166588
[TBL] [Abstract][Full Text] [Related]
15. Primary, unilateral ocular adnexal lymphoma: disease progression and long-term survival.
Rootman DB; Mavrikakis I; Connors JM; Rootman J
Ophthalmic Plast Reconstr Surg; 2011; 27(6):405-9. PubMed ID: 21659919
[TBL] [Abstract][Full Text] [Related]
16. The treatment results in patients with lmphoma disease in the orbit.
Furdová A; Marková A; Kapitánová K; Zahorjanová P
Cesk Slov Oftalmol; 2018; 73(5-6):211-217. PubMed ID: 30541302
[TBL] [Abstract][Full Text] [Related]
17. Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor.
Graue GF; Finger PT; Maher E; Della Rocca D; Della Rocca R; Lelli GJ; Milman T
Eur J Ophthalmol; 2013; 23(3):344-55. PubMed ID: 23397158
[TBL] [Abstract][Full Text] [Related]
18. Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study.
Vest SD; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Hindso TG; Holm F; Honavar SG; Khong JJ; Kirkegaard MK; McKelvie PA; Mikkelsen LH; Mulay K; Rasmussen PK; Siersma V; Sjö LD; Sniegowski MC; Thuro BA; Vemuganti GK; Heegaard S
Br J Ophthalmol; 2023 Sep; 107(9):1231-1238. PubMed ID: 35512851
[TBL] [Abstract][Full Text] [Related]
19. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa.
Lee JL; Kim MK; Lee KH; Hyun MS; Chung HS; Kim DS; Shin SO; Cho HS; Bae SH; Ryoo HM
Ann Hematol; 2005 Jan; 84(1):13-8. PubMed ID: 15309523
[TBL] [Abstract][Full Text] [Related]
20. [Ocular natural killer/T cell lymphoma: a clinicopathologic analysis].
Bi YW; Wang SY; Qian J; Yuan YF; Li XQ; Zhu XZ
Zhonghua Yan Ke Za Zhi; 2019 May; 55(5):374-380. PubMed ID: 31137150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
